Physician profile
Brent E Schultz
NPI 1760682660
$1,912.49
in general payments reported to CMS, 2019-2025
14 companies · $81.48 in 2025
The $81.48 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.92 · 2020: $151 · 2021: $619 · 2022: $294 · 2023: $654 · 2024: $82.86 · 2025: $81.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,187.56 | 2020-2025 | Integra, Tenoglide, Primatrix |
| Axogen | $159.94 | 2022-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Acumed LLC | $148.72 | 2021 | |
| Medartis INC. | $98.33 | 2023 | Aptus |
| Stryker Corporation | $87.86 | 2021-2022 | |
| Djo, LLC | $59.93 | 2023 | Cmf |
| Tela Bio, INC. | $34.27 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Depuy Synthes Sales INC. | $32.29 | 2020 | |
| Sonex Health, INC. | $28.36 | 2023 | Sx-One Microknife |
| Pacira Pharmaceuticals Incorporated | $23.44 | 2022 | |
| Acera Surgical, INC. | $15.95 | 2025 | Restrata Wound Matrix |
| Ucb, INC. | $15.27 | 2019 | |
| Genzyme Corporation | $14.65 | 2019 | |
| Orthofix Medical, INC. | $5.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.